New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
September 30, 2014
18:38 EDTNFLXAMC joins IMAX theater boycott of Netflix original movie, Deadline reports
Subscribe for More Information
16:39 EDTMRKCMS discloses drug makers' payments to doctors, WSJ says
Subscribe for More Information
16:00 EDTNFLXOptions Update; September 30, 2014
iPath S&P 500 VIX Short-Term Futures up 37c to 31.18. Option volume leaders: AAPL TSLA NFLX BAC TWTR AMZN HTZ DOW C F NFLX PBR according to Track Data.
14:52 EDTGDOTFirstEnergy warns customers about Green Dot card payment scam
FirstEnergy Corp.'s (FE) utilities are warning customers about a scam involving a telephone caller posing as a utility company employee threatening to shut off power unless an immediate payment is made using a pre-paid debit card such as a Green Dot (GDOT) card. Scams involving callers asking for utility bill payment via Green Dot cards have been reported by customers in all of FirstEnergy's service areas from Ohio to New Jersey, which include: Ohio Edison, The Illuminating Company and Toledo Edison in Ohio; West Penn Power, Penn Power, Met-Ed and Penelec in Pennsylvania; Jersey Central Power & Light in New Jersey; Mon Power in West Virginia; and Potomac Edison in West Virginia and Maryland. FirstEnergy and its utilities do not require payment over the phone via specific means, including Green Dot cards. Moreover, FirstEnergy's utilities do not demand payment over the phone to avoid an impending termination of service. "If you receive a call demanding payment via a specific option, including a Green Dot card, it's a scam, and you should report this crime to your local authorities," said Ronald I. Green, vice president, Customer Service, FirstEnergy. "While we may phone a customer whose bill is in arrears to remind them a payment is due, we would explain how a payment can be made using established payment options."
13:42 EDTNFLXRegal, Cinemark will not play Netflix original movie, Hollywood Reporter says
Subscribe for More Information
11:44 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:33 EDTNFLXNetflix announces first original movie to premiere on Netflix, IMAX theaters
Subscribe for More Information
08:16 EDTMRKTetraphase price target raised to $32 from $20 at JMP Securities
Subscribe for More Information
06:56 EDTNFLXGoogle, Netflix hindered from TV review by CRTC, Bloomberg says
Subscribe for More Information
06:42 EDTNFLXMovie sequel to be released directly to Netflix, NY Times reports
Subscribe for More Information
September 29, 2014
17:08 EDTCTRPPriceline reports 5.84% stake in Ctrip.com
Subscribe for More Information
16:54 EDTNFLXNetflix in talks on feature film with Weinstein Co., Bloomberg says
Subscribe for More Information
11:40 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTMCKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTMATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:48 EDTALKSAlkermes management to meet with Leerink
Meetings to be held in Canada October 6-7 hosted by Leerink.
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:22 EDTMATMattel downgraded to Neutral from Buy at MKM Partners
Subscribe for More Information
07:26 EDTMRKInforma Business Information to hold a conference
Subscribe for More Information
07:25 EDTDELLOracle to hold a conference
Open World 2014 to be held in San Francisco on September 28-October 2.
06:59 EDTMATMattel downgraded to Neutral from Buy at MKM Partners
05:44 EDTMRKMerck announces early data from investigational use of KEYTRUDA
Merck announced the first presentation of data on the investigational use of KEYTRUDA, the company’s anti-PD-1 therapy, in PD-L1 positive, advanced urothelial cancer. The early findings presented showed a confirmed overall response rate of 24% with KEYTRUDA as monotherapy, as measured by RECIST v1.1, central review including a complete response rate of 10%. At the time of analysis, response durations ranged from 16+ to 40+ weeks with six of the seven responders continuing on therapy. In the ongoing study, 64% of patients screened had tumors that were determined to be positive for PD-L1 expression.
05:30 EDTMCKMcKesson initiated with an Overweight at Barclays
Target $223.
September 28, 2014
19:38 EDTCTRPCtrip.com to purchase certain premises in Sky SOHO
Subscribe for More Information
12:53 EDTMRKMerck announces first presentation of data on investigational use of KEYTRUDA
Subscribe for More Information
September 26, 2014
16:55 EDTMATMarket ends week lower after inversion crackdown, mixed data
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:31 EDTMRKLigand, Merck receive approval for NOXAFIL
Subscribe for More Information
September 25, 2014
17:50 EDTNFLXCompanies receive U.S. information requests on Comcast-TWC deal, Bloomberg says
Subscribe for More Information
16:00 EDTNFLXOptions Update; September 25, 2014
iPath S&P 500 VIX Short-Term Futures up 2.09 to 30.38. Option volume leaders: AAPL TSLA NFLX BAC TWTR AMZN BP PBR GILD DOW according to Track Data.
15:05 EDTCTRPData suggest Ctrip.com may beat Q3 revenue guidance, says Piper Jaffray
Piper Jaffray said its analysis of China hotel and air travel data in the first two months of Q3 suggests Ctrip.com should at least hit the high end of its 30%-35% revenue growth forecast and may beat it, but by a lower amount than the company has previously beat in prior quarters. The firm maintains its Neutral rating on Ctrip, citing the volatility in China travel fundamentals.
10:03 EDTNFLXNetflix, Rainbow Studios announce spin-off of Winx Club as original TV series
Netflix and Rainbow Studios announced an expansion to the Winx Club franchise with a spin-off series, Winx Club WOW: World of Winx, that will be exclusively available in all Netflix territories including France and Germany. The first of the two all-new seasons will be available by early 2016 with the second following in the autumn.
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:22 EDTMATMattel loses key Disney license to Hasbro, says BMO Capital
BMO Capital views Hasbro's (HAS) announcement of a deal Disney (DIS) to acquire the global toys rights to produce and sell dolls based on Disney Princess property starting in 2016 as a negative for Mattel (MAT). BMO says Matte currently holds the Disney Princess doll license, and that its expected to generate about $600M in 2014. The firm estimates the license currently contributes $0.30, or 15%, to Mattel's annual earnings. BMO has an Underperform rating on Mattel with a $31 price target.
07:21 EDTGDOTGreen Dot strength due to GoBank overdone, estimates cut at SunTrust
SunTrust said the pop in Green Dot (GDOT) shares yesterday related to GoBank's partnership with Wal-Mart (WMT) is overdone. The analyst cut 2014-2016 estimates, but raised its price target to $21 from $18, to reflect ongoing share losses at Wal-Mart, its largest customer, but notes downside could be limited if it exceeds its new conservative outlook. Shares are Neutral rated.
September 24, 2014
16:22 EDTMATOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a report showed that sales of new homes rose to their highest level in over six years in August. The volume and news flow were relatively light, which may be the case again tomorrow as many market participants celebrate the Jewish holiday of Rosh Hashanah. ECONOMIC EVENTS: In the U.S., new home sales rose 18.0% in August to a 504K unit rate, which was much higher than the expected 4.4% increase. COMPANY NEWS: Bed Bath & Beyond (BBBY) advanced $4.64, or 7.4%, to $67.33 after the home goods retailer last night reported second quarter earnings and revenue that surpassed analysts' consensus estimates. The better than expected report and rise in the stock comes a day after William Blair downgraded the stock yesterday morning... Citizen Financial (CFG), the U.S. retail bank unit of Royal Bank of Scotland (RBS), became the year's second largest IPO behind Alibaba (BABA) after 140M shares began trading on the NYSE this morning. The stock ended it first day up $1.58, or 7.35%, at $23.08, which was far cry from the advance seen by another of the day's new stock debuts. CyberArk (CYBR) priced 5.36M shares at $16.00, opened for trade at $25.00 and ended the day at $29.94, making for a rise of over 87% from its IPO pricing. MAJOR MOVERS: Among the notable gainers was Acorda Therapeutics (ACOR), which advanced $8.27, or 28.18%, to $37.62 after the company agreed to acquire Civitas Therapeutics for $525M in cash. Civitas, which was private, had been scheduled to come public via an IPO that was expected to happen later this week prior to the deal announcement. Also higher was Hasbro (HAS), which rose $2.01, or 3.8%, to $54.95 after striking a deal that gives the company global rights, excluding Japan, to develop dolls based on Disney's (DIS) princess characters, as well as Frozen, beginning in 2016. Mattel (MAT), which currently holds those rights, slid 40c, or 1.25%, to $31.67 in the wake of the news. Also lower were shares of Skechers (SKX), which fell $5.69, or 9.8%, to $52.40 after research firm SportscanInfo reported that the footwear maker's sales had fallen 3% last week. However, Sterne Agee recommended buying the stock on the weakness. INDEXES: The Dow rose 154.19, or 0.9%, to 17,210.06, the Nasdaq gained 46.53, or 1.03%, to 4,555.22, and the S&P 500 added 15.53, or 0.78%, to 1,998.30.
12:29 EDTNFLX20th Century Fox signs TV deal with Canadian Shomi, The Hollywood Reporter says
Subscribe for More Information
12:29 EDTGDOTOn The Fly: Midday Wrap
Subscribe for More Information
12:14 EDTNFLXNetflix responds to Comcast's extortion claims, Variety reports
Subscribe for More Information
09:52 EDTALKSAlkermes expects to receive $59M in connection to Acorda-Civitas deal
Subscribe for More Information
09:49 EDTGDOTGreen Dot's 2014 guidance incorporates Wal-Mart, says Piper Jaffray
Green Dot (GDOT) announced this morning that it will offer its GoBank product at Wal-Mart (WMT) stores nationwide by the end of October. Piper said GoBank has been piloted in a few stores in Texas and the launch has already been incorporated into Green Dot's 2014 guidance and accounts for relatively little in revenues. The firm views the news as a positive in total and said it shows continued traction within GoBank and its relationship with Wal-Mart. Shares of GoBank are Overweight rated with a $24 price target.
09:17 EDTNFLXComcast accuses TWC deal opponents of extortion, Re/code reports
Subscribe for More Information
09:05 EDTGDOTOn The Fly: Pre-market Movers
Subscribe for More Information
05:14 EDTGDOTGreen Dot, Wal-Mart announce nationwide rollout of GoBank
Subscribe for More Information
September 23, 2014
10:17 EDTCTRPCTA president sees Chinese spending $155B overseas this year, China Daily says
Subscribe for More Information
09:00 EDTMCKBofa/Merill special situations team to hold an analyst/industry conference call
Subscribe for More Information
07:33 EDTMRKOphthotech names Michael Atieh as EVP, Chief Financial and Business Officer
Ophthotech Corporation (OPHT) announced that Michael G. Atieh has been named EVP, Chief Financial and Business Officer and Treasurer effective September 30. Atieh replaces Bruce A. Peacock, Chief Financial and Business Officer and Treasurer, who has notified the company of his intention to retire effective September 30. Atieh spent the majority of his career in the pharmaceutical industry with Merck and Co (MRK), where he held various senior level positions over a 20 year period including Senior Vice President-Merck Medco Managed Care, Vice President-U.S. Human Health, Vice President-Public Affairs, Vice President-Government Relations, and Treasurer.
06:48 EDTLTMLife Time Fitness REIT announcement coming soon, says Piper Jaffray
Piper Jaffray expects Life Time Fitness to make an announcement regarding board approval of moving forward with a REIT spin-off ahead of the company's Q3 results on October 23. Piper sees the announcement as the next catalysts for shares and recommends buying the stock at current levels. The firm thinks the stock could be worth $61 with a REIT structure, but adds "one could argue for a value above $70." Piper reiterates an Overweight rating on Life Time Fitness with a $61 price target.
06:48 EDTNFLXNetflix declines providing CRTC subscriber information, Globe and Mail says
Subscribe for More Information
05:54 EDTNFLXStocks with implied volatility movement; NFLX AMZN
Subscribe for More Information
September 22, 2014
16:00 EDTNFLXOptions Update; September 22, 2014
iPath S&P 500 VIX Short-Term Futures up 91c to 28.14. Option volume leaders: AAPL TSLA NFLX C TWTR AMZN BP PBR CLF WLT according to Track Data.
06:51 EDTMRKMerck to host conference call
Subscribe for More Information
September 19, 2014
16:00 EDTNFLXOptions Update; September 19, 2014
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
05:18 EDTNFLXNetflix now available in France, Germany, four other European countries
Subscribe for More Information
September 18, 2014
16:27 EDTVVUSOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTNFLXOptions Update; September 18, 2014
Subscribe for More Information
14:09 EDTVVUSVIVUS rallies, mean-reverting to intraday trend line
The shares have traded in an extremely wide range today on nearly 20 times daily average volume. An intraday trend line appears currently to be broken. That line is at $4.60 now, and projecting forward would be at the $4.80 area by the close. At the current price of $4.50, support is at $4.41 and then at $4.32.
12:45 EDTVVUSOn The Fly: Midday Wrap
Subscribe for More Information
11:55 EDTMCKRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
09:36 EDTVVUSActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
09:32 EDTNFLXNetflix domestic estimates raised at ITG Research
ITG raised Netflix's domestic estimates given an acceleration in August. The firm's data indicates a faster than expected improvement in ASP and improved churn trends. The analyst raised its Q3 domestic streaming revenue of $881.3M from $877.3M, above guidance of $877M and consensus of $876.3M.
09:02 EDTMCKRite Aid sees current competitive enviornment to remain promotional in FY15
Subscribe for More Information
08:59 EDTVVUSOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTMRKNeogen's dairy genomic program to be marketed by Merck
Subscribe for More Information
06:12 EDTGDOTGreen Dot to acquire Santa Barbara Tax Products Group for $320M
Subscribe for More Information
06:08 EDTGDOTGreen Dot expects to launch 'major new program' to make positive 2014 impact
Subscribe for More Information
06:06 EDTGDOTGreen Dot cuts FY14 adjusted EBITDA to $122M-$126M from $128M-$132M
Subscribe for More Information
06:05 EDTGDOTGreen Dot cuts FY14 non-GAAP revenue to $610M-$620M from $640M-$650M
Subscribe for More Information
06:05 EDTVVUSVIVUS, Auxilium announce FDA approval of STENDRA sNDA
VIVUS (VVUS) and Auxilium Pharmaceuticals (AUXL) announced that the FDA has approved a supplemental new drug application, or sNDA, for STENDRA. STENDRA is now the only FDA-approved erectile dysfunction, or ED, medication indicated to be taken as early as approximately 15 minutes before sexual activity. STENDRA is a prescription medication in a class of drugs known as phosphodiesterase type 5, or PDE5, inhibitors approved for the treatment of ED in men 18 years or older. STENDRA is available in multiple dosage strengths and may be taken with or without food and moderate alcohol consumption. In clinical studies, when compared to placebo, STENDRA helped more men achieve an erection in as early as approximately 15 minutes that lasted long enough to successfully complete sexual intercourse.
06:04 EDTGDOTGreen Dot cuts FY14 non-GAAP EPS $1.25-$1.29 from $1.37-$1.41, consensus $1.42
Subscribe for More Information
06:00 EDTNFLXNetflix implied volatility of 26 at lower end of index mean range
Subscribe for More Information
September 17, 2014
09:33 EDTMRKMerck announced positive results from Phase 3 data for omarigliptin
Subscribe for More Information
08:31 EDTMRKMerck, Sun Pharma enter into licensing agreement for Tildrakizumab
Merck and Sun Pharmaceutical Industries, through their respective subsidiaries,announced an exclusive worldwide licensing agreement for Merck’s investigational therapeutic antibody candidate, tildrakizumab, which is currently being evaluated in Phase 3 registration trials for the treatment of chronic plaque psoriasis, a skin ailment. Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of $80M. Merck will continue all clinical development and regulatory activities, which will be funded by Sun Pharma. Upon product approval, Sun Pharma will be responsible for regulatory activities, including subsequent submissions, pharmacovigilance, post approval studies, manufacturing and commercialization of the approved product. Merck is eligible to receive undisclosed payments associated with regulatory and sales milestones, as well as tiered royalties ranging from mid-single digit through teen percentage rates on sales. The transaction is subject to customary closing conditions, including the requirements under the Hart Scott-Rodino Antitrust Improvements Act.
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use